Tobias Stuwe

Tobias Stuwe's work experience began in 2001 at the University of Heidelberg, where they worked as an Undergraduate Student until 2006. Tobias then moved on to Rockefeller University and served as a Diploma/Master student from 2006 to 2007. Following that, Tobias worked at EMBL as a PhD student from 2007 to 2010. Tobias then joined Caltech as a Senior Postdoctoral Fellow from 2010 to 2015. In 2016, Tobias started working for Octapharma, where they held the roles of Group manager R&D from 2016 to 2018 and Head of Recombinant R&D from 2018 to 2021. Currently, they are the Vice President Protein Therapeutics at Odyssey Therapeutics, starting in November 2021.

Tobias Stuwe has a Master of Science (M.Sc.) degree in Biochemistry and Biology from Heidelberg University.